Cells develop a heterogeneous response to KRAS inhibitors, bypassing their anti-growth effects by producing more of the protein that does not bind the inhibitor.

中文翻译：

---

KRASG12C抑制剂的耐药性迫在眉睫。

细胞会通过产生更多不与抑制剂结合的蛋白质来绕过KRAS抑制剂的异质反应，从而绕开其抗生长作用。